• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磺胺类药物对卡氏肺孢子虫二氢蝶酸合酶的抑制作用。

Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.

作者信息

Merali S, Zhang Y, Sloan D, Meshnick S

机构信息

Department of Chemistry, City University of New York Medical School, City College of City University of New York, New York 10031.

出版信息

Antimicrob Agents Chemother. 1990 Jun;34(6):1075-8. doi: 10.1128/AAC.34.6.1075.

DOI:10.1128/AAC.34.6.1075
PMID:2203302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC171761/
Abstract

A new reversed-phase high-pressure liquid chromatography assay procedure for dihydropteroate synthetase (DHPS) that involves the elution of the enzyme incubation solution with a series of three solvents of decreasing polarity (ammonium phosphate buffer, 10% methanol, and 50% methanol) was designed. By this procedure DHPS was detected in Escherichia coli and Pneumocystis carinii with specific activities of 450 and 14 U/mg, respectively. A comparison of the effects of five sulfa drugs on P. carinii DHPS activity revealed that dapsone is the most potent of these drugs.

摘要

设计了一种新的用于二氢蝶酸合酶(DHPS)的反相高效液相色谱分析方法,该方法涉及用一系列三种极性递减的溶剂(磷酸铵缓冲液、10%甲醇和50%甲醇)洗脱酶孵育溶液。通过该方法,在大肠杆菌和卡氏肺孢子虫中检测到了DHPS,其比活性分别为450和14 U/mg。比较了五种磺胺药物对卡氏肺孢子虫DHPS活性的影响,结果表明氨苯砜是这些药物中最有效的。

相似文献

1
Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.磺胺类药物对卡氏肺孢子虫二氢蝶酸合酶的抑制作用。
Antimicrob Agents Chemother. 1990 Jun;34(6):1075-8. doi: 10.1128/AAC.34.6.1075.
2
Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.磺胺类药物对重组卡氏肺孢子虫二氢蝶酸合酶的抑制作用。
Antimicrob Agents Chemother. 1995 Aug;39(8):1756-63. doi: 10.1128/AAC.39.8.1756.
3
Quantitative structure-activity relationship studies of a series of sulfa drugs as inhibitors of Pneumocystis carinii dihydropteroate synthetase.一系列磺胺类药物作为卡氏肺孢子虫二氢蝶酸合酶抑制剂的定量构效关系研究。
Antimicrob Agents Chemother. 1998 Jun;42(6):1454-8. doi: 10.1128/AAC.42.6.1454.
4
Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia.复发性卡氏肺孢子虫肺炎中的磺胺耐药性及二氢蝶酸合酶突变体
Emerg Infect Dis. 2003 Jul;9(7):864-7. doi: 10.3201/eid0907.030249.
5
Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).
J Infect Dis. 1994 Feb;169(2):456-9. doi: 10.1093/infdis/169.2.456.
6
Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.对氨基苯甲酸对卡氏肺孢子虫二氢蝶酸合酶的抑制作用:异丙肌苷在人类免疫缺陷病毒感染中可能的作用机制。
Antimicrob Agents Chemother. 1993 Jun;37(6):1227-31. doi: 10.1128/AAC.37.6.1227.
7
Structure-activity of sulfones and sulfonamides on dihydropteroate synthetase from Neisseria meingitidis.砜类和磺胺类药物对脑膜炎奈瑟菌二氢蝶酸合酶的构效关系
Antimicrob Agents Chemother. 1975 Jun;7(6):758-63. doi: 10.1128/AAC.7.6.758.
8
Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.卡氏肺孢子虫二氢蝶酸合酶而非二氢叶酸还原酶基因突变与先前使用甲氧苄啶-磺胺甲恶唑或氨苯砜有关。
J Infect Dis. 1999 Dec;180(6):1969-78. doi: 10.1086/315148.
9
Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.日本卡氏肺孢子虫人亚种分离株二氢蝶酸合酶突变与磺胺类药物治疗耐药性的关系。
J Clin Microbiol. 2000 Sep;38(9):3161-4. doi: 10.1128/JCM.38.9.3161-3164.2000.
10
Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.鉴定出一类对刚地弓形虫、卡氏肺孢子虫和鸟分枝杆菌的二氢蝶酸合酶具有高活性的磺胺类药物。
Antimicrob Agents Chemother. 1996 Mar;40(3):727-33. doi: 10.1128/AAC.40.3.727.

引用本文的文献

1
The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.6-羟甲基-7,8-二氢蝶呤焦磷酸激酶新型抑制剂的鉴定、分析及基于结构的开发
Bioorg Med Chem. 2014 Apr 1;22(7):2157-65. doi: 10.1016/j.bmc.2014.02.022. Epub 2014 Feb 25.
2
Catalysis and sulfa drug resistance in dihydropteroate synthase.二氢叶酸合成酶中的催化作用和磺胺类药物耐药性。
Science. 2012 Mar 2;335(6072):1110-4. doi: 10.1126/science.1214641.
3
Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.鉴定出一类对刚地弓形虫、卡氏肺孢子虫和鸟分枝杆菌的二氢蝶酸合酶具有高活性的磺胺类药物。
Antimicrob Agents Chemother. 1996 Mar;40(3):727-33. doi: 10.1128/AAC.40.3.727.
4
6,7-disubstituted 2,4-diaminopteridines: novel inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.6,7-二取代的2,4-二氨基蝶啶:卡氏肺孢子虫和刚地弓形虫二氢叶酸还原酶的新型抑制剂。
Antimicrob Agents Chemother. 1996 Jun;40(6):1371-5. doi: 10.1128/AAC.40.6.1371.
5
Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.磺胺类药物对重组卡氏肺孢子虫二氢蝶酸合酶的抑制作用。
Antimicrob Agents Chemother. 1995 Aug;39(8):1756-63. doi: 10.1128/AAC.39.8.1756.
6
Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs.磺胺类药物对恶性疟原虫二氢蝶酸合酶的抑制作用及其体外生长抑制
Antimicrob Agents Chemother. 1991 Feb;35(2):267-71. doi: 10.1128/AAC.35.2.267.
7
Acquisition and synthesis of folates by obligate intracellular bacteria of the genus Chlamydia.衣原体属专性细胞内细菌对叶酸的获取与合成。
J Clin Invest. 1992 Nov;90(5):1803-11. doi: 10.1172/JCI116055.

本文引用的文献

1
THE ENZYMATIC SYNTHESIS OF FOLATE-LIKE COMPOUNDS FROM HYDROXYMETHYLDIHYDROPTERIDINE PYROPHOSPHATE.由焦磷酸羟甲基二氢蝶啶酶促合成类叶酸化合物
J Biol Chem. 1964 Jul;239:2259-66.
2
Radioassay for dihydropteroate-synthesizing enzyme activity.
Methods Enzymol. 1980;66:560-4. doi: 10.1016/0076-6879(80)66507-0.
3
Inhibition of dihydropteroate synthetase from Escherichia coli by sulfones and sulfonamides.砜类和磺胺类药物对大肠杆菌二氢蝶酸合酶的抑制作用。
Antimicrob Agents Chemother. 1973 Jun;3(6):665-9. doi: 10.1128/AAC.3.6.665.
4
Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.甲氧苄啶和磺胺甲恶唑在预防和治疗卡氏肺孢子虫肺炎中的疗效。
Antimicrob Agents Chemother. 1974 Mar;5(3):289-93. doi: 10.1128/AAC.5.3.289.
5
Micro procedure for determination of pyrophosphate and orthophosphate.焦磷酸盐和正磷酸盐测定的微量方法。
Anal Biochem. 1970 Jan;33(1):114-9. doi: 10.1016/0003-2697(70)90444-6.
6
An improved method of isolating Pneumocystis carinii from infected rat lungs.
J Parasitol. 1986 Oct;72(5):690-8.
7
Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.氨苯砜治疗获得性免疫缺陷综合征中的卡氏肺孢子虫肺炎。
Antimicrob Agents Chemother. 1988 Jul;32(7):1057-60. doi: 10.1128/AAC.32.7.1057.
8
Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.预防卡氏肺孢子虫肺炎时不同剂量、给药间隔及药物的比较。
Antimicrob Agents Chemother. 1988 May;32(5):623-5. doi: 10.1128/AAC.32.5.623.
9
Treatment of Pneumocystis carinii pneumonia with trimetrexate in acquired immunodeficiency syndrome (AIDS).
Semin Oncol. 1988 Apr;15(2 Suppl 2):46-9.
10
Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions.
Ann Intern Med. 1989 Apr 15;110(8):606-11. doi: 10.7326/0003-4819-110-8-606.